Host nucleolin-targeting unique peptide drugs as potent broad-spectrum anti-influenza therapies

Clicks: 18
ID: 327395
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #79 of 151 articles by views in PNAS nexus

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 151 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The persistent threat of influenza pandemics and seasonal outbreaks, coupled with rising resistance to existing antiviral drugs targeting influenza viruses, necessitates the development of new therapeutics. This study investigated the antiviral potential of cell-penetrating peptide-conjugated host nucleolin (NCL)-binding peptide drugs, AGM-380d (dimeric) and AGM-380t (tetrameric), as innovative, broad-spectrum host-directed anti-influenza therapies. Infection with both influenza A and B viruses (IAVs and IBVs) significantly increased NCL expression and colocalization with viral nucleoprotein (NP), a core component of viral ribonucleoprotein complexes, in both in vitro and in vivo settings. The peptide drugs rapidly localized to the nucleolus and specifically bound to NCL. This targeted binding successfully disrupted the interaction between NCL and the NP of IAV and IBV, effectively blocking nuclear NP trafficking and inhibiting the replication of both pandemic and seasonal strains. Importantly, AGM-380d and AGM-380t protected mice from lethal IAV challenge by markedly reducing lung viral replication and pathology. The combination of AGM-380t with oseltamivir resulted in 100% protection from mortality following the deadly IAV challenge. In conclusion, AGM-380d and AGM-380t are highly promising as novel, broad-spectrum host-directed antivirals for the management of seasonal and pandemic influenza.
Reference Key
openalex_W7204922144 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Thu Ha Nguyen, Muhammad Anees Sharif, Jae-Hyun Kim, Yeong‐Bin Baek, Mahmoud Soliman, Hyung-Jun Kwon, Seong-Hun Jeong, Ragab Farouk, Shaimaa Aboelmagd, Jae‐Ha Ryu, Gyeong Min Kim, Woonsung Na, Don‐Kyu Kim, Jeong-Sun Kim, Dong Ju Lee, Jae Il Kim, Kyoung‐Oh Cho
Are you one of these authors? Claim your profile
Journal PNAS nexus
Year 2026
DOI
10.1093/pnasnexus/pgag269
URL
https://academic.oup.com/pnasnexus/article-pdf/5/9/pgag269/70834659/pgag269.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.